Q4 Earnings Estimate for Cresco Labs Issued By Roth Capital

Cresco Labs Inc. (OTCMKTS:CRLBFFree Report) – Roth Capital issued their Q4 2024 earnings estimates for Cresco Labs in a report issued on Sunday, November 10th. Roth Capital analyst W. Kirk forecasts that the company will earn ($0.01) per share for the quarter. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Roth Capital also issued estimates for Cresco Labs’ Q1 2025 earnings at ($0.01) EPS, Q2 2025 earnings at $0.00 EPS, Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.00 EPS and FY2025 earnings at ($0.01) EPS.

CRLBF has been the topic of several other reports. Cormark lowered shares of Cresco Labs from a “moderate buy” rating to a “hold” rating in a research note on Monday. Needham & Company LLC restated a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Finally, Ventum Cap Mkts upgraded shares of Cresco Labs to a “strong-buy” rating in a research report on Friday, August 9th. Three equities research analysts have rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, Cresco Labs presently has a consensus rating of “Moderate Buy” and an average target price of $2.50.

View Our Latest Research Report on Cresco Labs

Cresco Labs Stock Down 2.8 %

CRLBF stock opened at $1.40 on Wednesday. The firm has a market capitalization of $683.40 million, a price-to-earnings ratio of -7.20 and a beta of 1.88. Cresco Labs has a fifty-two week low of $1.02 and a fifty-two week high of $2.65. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.30 and a current ratio of 2.00. The company’s 50 day moving average price is $1.58 and its 200 day moving average price is $1.70.

About Cresco Labs

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Recommended Stories

Earnings History and Estimates for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.